Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 14;20(12):2922.
doi: 10.3390/ijms20122922.

Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play A Role?

Affiliations
Review

Obesity, Insulin Resistance, and Colorectal Cancer: Could miRNA Dysregulation Play A Role?

Francesca Cirillo et al. Int J Mol Sci. .

Abstract

Obesity is associated with insulin resistance and low-grade inflammation. Insulin resistance is a risk factor for cancer. A recent chapter in epigenetics is represented by microRNAs (miRNAs), which post-transcriptionally regulate gene expression. Dysregulated miRNA profiles have been associated with diseases including obesity and cancer. Herein we report dysregulated miRNAs in obesity both in animal models and in humans, and we also document dysregulated miRNAs in colorectal cancer (CRC), as example of an obesity-related cancer. Some of the described miRNAs are found to be similarly dysregulated both in obesity, insulin resistance (IR), and CRC. Thus, we present miRNAs as a potential molecular link between obesity and CRC onset and development, giving a new perspective on the role of miRNAs in obesity-associated cancers.

Keywords: cancer; colorectal cancer; inflammation; insulin resistance; microRNA; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Dysregulated microRNAs in common between obesity and colorectal cancer (CRC), possibly linking the two conditions.

Similar articles

Cited by

References

    1. Stolarczyk E. Adipose tissue inflammation in obesity: A metabolic or immune response? Opin. Pharmacol. 2017;37:35–40. doi: 10.1016/j.coph.2017.08.006. - DOI - PubMed
    1. Liu Y., Han Z.P., Zhang S.S., Jing Y.Y., Bu X.X., Wang C.Y., Sun K., Jiang G.C., Zhao X., Li R., et al. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J. Biol. Chem. 2011;286:25007–25015. doi: 10.1074/jbc.M110.213108. - DOI - PMC - PubMed
    1. Cohen D.H., LeRoith D. Obesity, type 2 diabetes, and cancer: The insulin and IGF connection. Endocr. Relat. Cancer. 2012;19:F27–F45. doi: 10.1530/ERC-11-0374. - DOI - PubMed
    1. Lebovitz H.E. Insulin resistance: Definition and consequences. Exp. Clin. Endocrinol. Diabetes. 2001;109:S135–S148. doi: 10.1055/s-2001-18576. - DOI - PubMed
    1. Shanmugalingam T., Bosco C., Ridley A.J., Van Hemelrijck M. Is there a role for IGF-1 in the development of second primary cancers? Cancer Med. 2016;5:3353–3367. doi: 10.1002/cam4.871. - DOI - PMC - PubMed